Instructions for Nurofen EXPRESS LADY (Ibuprofen) 400 mg 12 pills
English product name
Nurofen® Express Lady
Release form
Shell-coated tablets
Description Nurofen:
The tablets are covered with a white shell and are round and double-convex, with a red overprint "N>>" on one side.
- 1 tab.
- ibuprofen sodium dihydrate 512 mg,
- which corresponds to ibuprofen content 400 mg
- Auxiliary substances: sodium croskarmellosis - 60 mg,
- xylitol - 60 mg,
- microcrystalline cellulose - 60 mg,
- magnesium stearate - 16 mg,
- silicon dioxide colloidal - 4 mg.
Shell Composition Nurofen:
- sodium carmellose - 1 mg,
- talc - 48 mg,
- acacia gum - 1.6 mg,
- sucrose - 186.2 mg,
- titanium dioxide (E171) - 3.3 mg,
- macrogol 6000 - 0.5 mg,
- ink red [Opacod S-1-15094] (shellac 41.49%, iron oxide (E172) 31%, butanol* 14%, isopropanol* 7%, propylene glycol 5.5%, ammonia 1%, seaweed methicone 0.01%).
ATC codes
M01AE01 Ibuprofen
Clinical-pharmacological groups / Group affiliation
NAPS
Active substance
ibuprofen
Pharmacotherapy group
NSAIDs
Proof of the drug Nurofen:
Symptomatic treatment as anti-inflammatory and heat-saving means:
inflammatory-degenerative diseases of joints and spinal cord (including rheumatic and rheumatoid arthritis, ankytizing sponditis, osteoartrosis), joint syndrome in the event of aggravation Gifts, psoriatic arthritis, ankytizing spondylite, tendinitis, bursitis, radikulite, traumatic inflammation of soft tissues and motor-support apparatus. Neuralgia, myalgia, disease syndrome in infectious-inflammatory diseases of LOR-organs, adnexite, algodismenorrhea, headache and tooth pain. Likhoradka for infectious and inflammatory diseases, for childhood infections, for post-vaccine reactions in children (in appropriate medicinal forms).
Method of application, course and dosage:
They establish individually, depending on the testimony, the expression of clinical manifestations, the age of the patient.
kidney damage
Contrary to reported kidney failure. Carefully applied for associated kidney diseases.
liver function violation Nurofen
Contrary to reported liver function violations. Careful use of liver for associated diseases.
Application to older patients
Care should be taken to assign older patients to avoid the deterioration of the associated diseases.
Older patients have an increased frequency of side-effects, especially gastrointestinal bleeding and perforation, in some cases fatal.
Child use Nurofen
Ibuprofen is contrasted for rectal use in children with a body mass of up to 6 kg; For oral use, children under 6 years of age (in doses of 200 mg), children under 12 years of age (in doses of 400 mg).
Nosology Nurofen (ICD codes)
- H92.0
- Otalgia
- K08.8
- Other refined changes to the teeth and their control apparatus (including tooth pain)
- M05
- Gray-positive rheumatoid arthritis
- M07
- Psyriatic and enteropathic arthropathy
- M10
- Podagra
- M15
- Polyarthrosis
- M19.9
- Arthrosis Unspecified
- M25.5
- Pain in the joint
- M42
- Osteochondrosis spine
- M45
- Ankyling Spondilitis
- M47
- Spondelise
- M54
- Dorsalgia
- M54.1
- Radiculopathy
- M54.3
- Ishias
- M54.4
- Lumbago with Chias
- M65
- Synovites and Tenosinovites
- M70
- Sick tissue diseases due to load, congestion and pressure
- M71
- Other Boursopathy
- M79.1
- Milgia
- M79.2
- Neuralgia and Neutral Unspecified
- N70
- Salping and Offorite
- N94.4
- Primary Dismenorium
- N94.5
- Secondary Dismantlement
- R07.0
- Gore pain
- R50
- An obscure-origin dick
- R51
- Headache
- R52.0
- Acute pain
- R52.2
- Other permanent pain (chronic)
- T14.3
- Stretch, stretch, and over-voltage the capsule-bound joint of the unrefined body area
Pharmacy Nurofen:
NIPA, derived from phenylpropionic acid. Provides anti-inflammatory, analgetizing and heat-reducing effects.
The mechanism of action is related to the suppression of the activity of the TsOC, the main ferment of peanut acid metabolism, a precursor to prostate-glandins, which play a major role in the pathogenesis of inflammation, pain and fever. Analgesifying effect is caused both by peripheral (indirectly, through the suppression of the synthesis of prostate glandins) and by the central mechanism (inhibiting the synthesis of prostate glandins in the central and peripheral nervous system). Suppresses the aggregation of platelets.